CLINICAL_TRIALS
trial_result
· 2022-08-08
Clinical Trial Update: Long Term Extension Study of Tapinarof for Plaque Psoriasis in Adults (3003) [Phase 3]
Summary
Long-term extension data from a Phase 3 study of Tapinarof in adults with plaque psoriasis have completed. The extension results were posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2022-08-08